In VivoIn the top alliance by deal value, Pfizer entered into an exclusive global, ex-China, licensing agreement with 3SBio for the development, manufacturing, and commercialization of SSGJ-707, a bispecific
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Rznomics To Partner With Lilly On
Pink SheetChanges made to transferable exclusivity vouchers (TEVs) for antimicrobials, introduced as part of the EU pharmaceutical legislative reform package, will “weaken” their value to the point that they ar
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Daiichi Sankyo Tries Wayfinder’s